(Q77873031)
Statements
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group (English)
Hochberg MC
Ross PD
Black D
Cummings SR
Genant HK
Nevitt MC
Musliner T